VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US Patent 11,390,651Filed on 2020-08-31
Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 Read more about Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 US Patent 11,753,627Filed on 2020-09-01
USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS Read more about USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS Hong Kong19127785.4Filed on 2017-04-18
BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE US Patent 11,369,675Filed on 2020-07-21
BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE India202017031357Filed on 2019-01-18
BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE European Patent19717381.8Filed on 2019-01-18
BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE China201980009484.7Filed on 2019-01-18
Zika Viral Antigen Constructs Read more about Zika Viral Antigen Constructs European Patent17804131.5Filed on 2017-11-15
Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease Read more about Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease Poland14826325.4Filed on 2014-07-18
Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease Read more about Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease Italy14826325.4Filed on 2014-07-18